Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

9F (JFU) Cash & Equivalents (2017 - 2025)

9F has reported Cash & Equivalents over the past 9 years, most recently at $45.9 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 92.63% to $45.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.9 million through Dec 2025, up 92.63% year-over-year, with the annual reading at $62.1 million for FY2025, 14.55% up from the prior year.
  • Cash & Equivalents was $45.9 million for Q4 2025 at 9F, down from $58.7 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $382.2 million in Q4 2021 and troughed at $23.8 million in Q4 2024.
  • The 5-year median for Cash & Equivalents is $262.5 million (2021), against an average of $214.9 million.
  • Year-over-year, Cash & Equivalents tumbled 89.83% in 2024 and then surged 92.63% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $382.2 million in 2021, then dropped by 10.48% to $342.1 million in 2022, then plummeted by 31.54% to $234.2 million in 2023, then tumbled by 89.83% to $23.8 million in 2024, then surged by 92.63% to $45.9 million in 2025.
  • Per Business Quant, the three most recent readings for JFU's Cash & Equivalents are $45.9 million (Q4 2025), $58.7 million (Q2 2025), and $23.8 million (Q4 2024).